Replies to post #167840 on Biotech Values

[DewDiligence]

ARIA—Why would any doctor do that for 1st line or even 2nd line? It is not like there aren't any other choices.

Your’e addressing a different question than the one I posited. I wasn’t arguing for Iclusig use in any particular setting, but rather was suggesting that patients who do receive Iclusig could benefit from an antiplatelet drug. The downside of adding one to the regimen would seem to be small.

[mcbio]

ARIA

I think they'll need long term data to really moving into 1st and 2nd line.

Define what you mean by "long term" here.